These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23184121)

  • 1. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.
    Flores-Luna L; Camorlinga-Ponce M; Hernandez-Suarez G; Kasamatsu E; Martínez ME; Murillo R; Lazcano E; Torres J
    Cancer Causes Control; 2013 Feb; 24(2):241-8. PubMed ID: 23184121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain.
    González CA; Figueiredo C; Lic CB; Ferreira RM; Pardo ML; Ruiz Liso JM; Alonso P; Sala N; Capella G; Sanz-Anquela JM
    Am J Gastroenterol; 2011 May; 106(5):867-74. PubMed ID: 21285949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer.
    López-Carrillo L; Torres-López J; Galván-Portillo M; Muñoz L; López-Cervantes M
    Eur J Cancer; 2004 Jul; 40(11):1752-9. PubMed ID: 15251166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological assessment of Helicobacter pylori-specific antibodies and their association with gastric lesions in a high-risk population].
    Liu C; Wang YM; Li ZX; Zhang L; Ma JL; Zhou T; You WC; Pan KF
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):547-51. PubMed ID: 24257311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia].
    Cittelly DM; Huertas MG; Martínez JD; Oliveros R; Posso H; Bravo MM; Orozco O
    Rev Med Chil; 2002 Feb; 130(2):143-51. PubMed ID: 11974526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori and response to treatment, in Chiapas, Mexico].
    Mohar A; Ley C; Guarner J; Herrera-Goepfert R; Sánchez L; Halperin D; Parsonnet J
    Gac Med Mex; 2002; 138(5):405-10. PubMed ID: 12412571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
    Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
    J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
    J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
    Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H
    Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
    Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.
    Groves FD; Perez-Perez G; Zhang L; You WC; Lipsitz SR; Gail MH; Fraumeni JF; Blaser MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1091-4. PubMed ID: 12376512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
    Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I
    Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.
    Cárdenas-Mondragón MG; Torres J; Flores-Luna L; Camorlinga-Ponce M; Carreón-Talavera R; Gomez-Delgado A; Kasamatsu E; Fuentes-Pananá EM
    Br J Cancer; 2015 Jun; 112(12):1866-73. PubMed ID: 25996206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.